EP Patent

EP4554566A1 — Budesonide two layers capsule formulation

Assigned to Synthon BV · Expires 2025-05-21 · 1y expired

What this patent protects

The present invention relates to a Budesonide formulation with one or more layers comprising organic acid and Budesonide in the same layer.

USPTO Abstract

The present invention relates to a Budesonide formulation with one or more layers comprising organic acid and Budesonide in the same layer.

Drugs covered by this patent

Pulmicort Respules (BUDESONIDE) · AstraZeneca K.K.

Patent Metadata

Patent number: EP4554566A1
Jurisdiction: EP
Classification: —
Expires: 2025-05-21
Drug substance claim: No
Drug product claim: No
Assignee: Synthon BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.